Johnson & Johnson stock slipped Tuesday after the company reported first-quarter earnings that surpassed expectations and boosted its full-year sales forecast. The pharmaceutical and biotech giant ...

The company continues to face litigation over its talc baby powder, taken off the market in 2023. Netflix Aims to Join the $1 Trillion Club The streaming service has shared financial performance ...

With recession concerns circulating in the market, Johnson & Johnson (JNJ) stock could stabilize many portfolios. Since its founding in ...

J&J recently lost a bid to settle lawsuits that claimed its talc powder products, including baby powder, caused cancer. Author Gardiner Harris says the company's defense "is beginning to crumble." ...

Except it really wasn’t, thanks to the asbestos in that “finest talc obtainable.” According to asbestos.com, in March of this ...

Johnson & Johnson’s latest bid to settle tens of thousands of talc-related lawsuits has been rejected by a U.S. bankruptcy ...

Health care giant Johnson & Johnson is one of the most well-known and respected brands, and its response to the 1982 ...

A U.S. bankruptcy court judge has denied Johnson & Johnson’s settlement plan related to baby powder containing talc, ...

A federal bankruptcy judge has rejected Johnson & Johnson’s latest attempt to settle lawsuits that allege its talc baby ...

A US judge has once again rejected Johnson & Johnson’s $10 billion bankruptcy settlement aimed at resolving baby ...

A Johnson & Johnson unit’s latest dismissal from the bankruptcy court system shows how complex voting issues and overly broad ...